A detailed history of Impact Partnership Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Impact Partnership Wealth, LLC holds 13,962 shares of GILD stock, worth $957,932. This represents 0.41% of its overall portfolio holdings.

Number of Shares
13,962
Previous 9,587 45.63%
Holding current value
$957,932
Previous $777 Million 31.7%
% of portfolio
0.41%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $313,162 - $381,893
4,375 Added 45.63%
13,962 $1.02 Billion
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $200,906 - $227,832
2,742 Added 40.06%
9,587 $777 Million
Q3 2023

Oct 17, 2023

BUY
$73.94 - $80.67 $200,229 - $218,454
2,708 Added 65.46%
6,845 $513 Million
Q2 2023

Jul 17, 2023

BUY
$76.01 - $86.7 $314,453 - $358,677
4,137 New
4,137 $319 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Impact Partnership Wealth, LLC Portfolio

Follow Impact Partnership Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Partnership Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impact Partnership Wealth, LLC with notifications on news.